Alnylam Pharmaceuticals, Inc.ALNYNASDAQ
LOADING
|||
Revenue Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
22.97%
↓ 60% below average
Average (9y)
58.10%
Historical baseline
Range
High:193.36%
Low:-18.72%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | 22.97% |
| 2023 | 76.23% |
| 2022 | 22.88% |
| 2021 | 71.31% |
| 2020 | 124.28% |
| 2019 | 193.36% |
| 2018 | -16.69% |
| 2017 | 90.66% |
| 2016 | 14.75% |
| 2015 | -18.72% |